The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
Clinical trial NCT05618041 · RECRUITING
Trial details
- NCT number
- NCT05618041
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-07
- Primary completion
- 2027-09-06
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.